We are live on ! Find out more
AI

Analytic Investors Portfolio holdings

AUM $8.93B
1-Year Est. Return 13.54%
This Fund
S&P 500
This Quarter Est. Return
+0.47%
1 Year Est. Return
+13.54%
3 Year Est. Return
+42.14%
5 Year Est. Return
10 Year Est. Return
AUM
$6.99B
AUM Growth
+$817M
Cap. Flow
+$874M
Cap. Flow %
12.5%
Top 10 Hldgs %
21.45%
Holding
727
New
213
Increased
170
Reduced
155
Closed
141

Top Buys

Rank Stock Value
1
MNST icon
Monster Beverage
MNST
+$79.6M
2
MCD icon
McDonald's
MCD
+$75.2M
3
RCI icon
Rogers Communications
RCI
+$74.7M
4
PG icon
Procter & Gamble
PG
+$73.6M
5
ETR icon
Entergy
ETR
+$71.4M

Top Sells

Rank Stock Value
1
BG icon
Bunge Global
BG
+$79.2M
2
DOX icon
Amdocs
DOX
+$71.1M
3
THI
TIM HORTONS INC COM, CANADA
THI
+$39.9M
4
K
Kellanova
K
+$37.9M
5
PFE icon
Pfizer
PFE
+$37.4M

Sector Composition

Rank Sector Weight
1 Consumer Staples 18.4%
2 Healthcare 13.83%
3 Financials 10.19%
4 Technology 10.02%
5 Utilities 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STE icon
376
Steris
STE
$22.3B
$778K 0.01%
14,412
+1,772
+14% +$96.3K
SANM icon
377
Sanmina
SANM
$8.93B
$766K 0.01%
36,734
+10,274
+39% +$239K
TCF
378
DELISTED
TCF Financial Corporation
TCF
$751K 0.01%
+48,376
New +$772K
ISRG icon
379
Intuitive Surgical
ISRG
$132B
$748K 0.01%
14,571
-103,320
-88% -$5.13M
FSS icon
380
Federal Signal
FSS
$7.19B
$739K 0.01%
55,830
-129,354
-70% -$1.88M
SGNT
381
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$737K 0.01%
23,685
-1,668
-7% -$45.2K
TRIP icon
382
TripAdvisor
TRIP
$1.7B
$735K 0.01%
+8,045
New +$797K
CSCO icon
383
Cisco
CSCO
$448B
$732K 0.01%
+29,080
New +$731K
CLW icon
384
Clearwater Paper
CLW
$291M
$729K 0.01%
12,135
-553
-4% -$36.6K
CBM
385
DELISTED
Cambrex Corporation
CBM
$728K 0.01%
38,950
+2,822
+8% +$60.6K
AIZ icon
386
Assurant
AIZ
$13.9B
$719K 0.01%
+11,180
New +$731K
GOOG icon
387
Alphabet (Google) Class C
GOOG
$4T
$717K 0.01%
24,427
-1,283
-5% -$37.1K
LSAK icon
388
Lesaka Technologies
LSAK
$391M
$714K 0.01%
59,268
ADSK icon
389
Autodesk
ADSK
$50.2B
$704K 0.01%
+12,769
New +$700K
SNV
390
DELISTED
Synovus
SNV
$699K 0.01%
29,562
DMC
391
Del Monte Corp
DMC
$1.4B
$687K 0.01%
+21,533
New +$673K
SWC
392
DELISTED
Stillwater Mining Co
SWC
$677K 0.01%
+45,015
New +$808K
DD icon
393
DuPont de Nemours
DD
$19.2B
$673K 0.01%
5,066
-235,760
-98% -$31.4M
ALE
394
DELISTED
Allete
ALE
$667K 0.01%
15,016
AES icon
395
AES
AES
$10.6B
$654K 0.01%
+46,115
New +$686K
ACH
396
Accendra Health
ACH
$244M
$640K 0.01%
19,548
-652
-3% -$22.2K
VRA icon
397
Vera Bradley
VRA
$106M
$636K 0.01%
30,769
IART icon
398
Integra LifeSciences
IART
$1.58B
$628K 0.01%
30,960
+11,696
+61% +$233K
UPBD icon
399
Upbound Group
UPBD
$1.22B
$627K 0.01%
20,674
-1,608
-7% -$43.2K
OPY icon
400
Oppenheimer Holdings
OPY
$1.18B
$622K 0.01%
30,719

Similar funds

Analytic Investors's Q3 2014 Portfolio in Review

As of Q3 2014, Analytic Investors held 727 positions worth $6.99B, up 13% from $6.18B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Analytic Investors deployed $874M of net new capital in Q3 2014, opening 213 new positions and adding to 170 existing holdings. Its largest new stake was Rogers Communications: 1,884,329 shares worth $70.7M.

By sector, the portfolio is most concentrated in Consumer Staples at 18% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Kellanova, an estimated $37.9M trimmed.

  • Analytic Investors's largest Q3 2014 buy was Rogers Communications: 1,884,329 shares worth $70.7M.
  • Analytic Investors added most to Monster Beverage in Q3 2014, an estimated $79.6M increase.
  • Analytic Investors's biggest Q3 2014 reduction was Kellanova, cutting an estimated $37.9M.
  • Analytic Investors fully exited Bunge Global in Q3 2014, selling an estimated $79.2M.
  • Analytic Investors's ten largest holdings make up 21% of its $6.99B portfolio in Q3 2014.
  • Analytic Investors opened 213 new positions and closed 141 in Q3 2014.
  • Analytic Investors's portfolio value rose 13% quarter-over-quarter to $6.99B.

Based on Analytic Investors's 13F filing for Q3 2014, filed 7 Nov 2014.